Abstract
Myocardial infarction (MI), which occurs often due to acute ischemia followed by reflow, is associated with irreversible loss (death) of cardiomyocytes. If left untreated, MI will lead to progressive loss of viable cardiomyocytes, deterioration of cardiac function, and congestive heart failure. While supplemental oxygen therapy has long been in practice to treat acute MI, there has not been a clear scientific basis for the observed beneficial effects. Further, there is no rationale for the amount or duration of administration of supplemental oxygenation for effective therapy. The goal of the present study was to determine an optimum oxygenation protocol that can be clinically applicable for treating acute MI. Using EPR oximetry, we studied the effect of exposure to supplemental oxygen cycling (OxCy) administered by inhalation of 21-100% oxygen for brief periods (15-90 min), daily for 5 days, using a rat model of acute MI. Myocardial oxygen tension (pO2), cardiac function and pro-survival/apoptotic signaling molecules were used as markers of treatment outcome. OxCy resulted in a significant reduction of infarct size and improvement of cardiac function. An optimal condition of 30-min OxCy with 95% oxygen + 5% CO2 under normobaric...Continue Reading
References
May 8, 1976·British Medical Journal·J M Rawles, A C Kenmure
Oct 1, 1990·American Heart Journal·M P ThomasD P Guyton
Oct 15, 1966·Lancet·A J CameronW R Murdoch
Mar 1, 1973·The American Journal of Cardiology·D P GilmourW H Abelmann
Oct 1, 1969·Postgraduate Medical Journal·R Ashfield, C J Gavey
Nov 9, 1968·British Medical Journal·A C KenmureA J Cameron
Apr 1, 1969·Cardiovascular Research·G L FosterT J Reeves
Jan 1, 1966·Circulation Research·R H PeterH D McIntosh
Oct 1, 1967·The American Journal of Cardiology·J P Shillingford, M Thomas
Oct 1, 1993·Circulation·D L SterlingJ M Downey
Oct 21, 1998·Cardiology·Y StavitskyD Clarke
Feb 1, 2003·European Heart Journal·Frans Van de WerfUNKNOWN Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology
Oct 17, 1964·Lancet·G J MACKENZIEK W DONALD
May 1, 1965·British Heart Journal·M THOMASJ SHILLINGFORD
Jun 1, 1965·Circulation Research·L A KUHNJ H JACOBSON
Oct 24, 2003·Free Radical Biology & Medicine·Ramasamy P PandianPeriannan Kuppusamy
Sep 11, 2004·Journal of the American College of Cardiology·Elliott M AntmanUNKNOWN Canadian Cardiovascular Society
Aug 26, 2006·Cardiovascular Research·Bernadette P CabigasJohn E Baker
Mar 7, 2007·Journal of the Royal Society of Medicine·Richard BeasleyDavid McHaffie
Jul 20, 2007·Heart·T BragadeeshS Kaul
Aug 19, 2008·Heart·M WijesingheR Beasley
Oct 22, 2008·Thorax·B R O'DriscollUNKNOWN British Thoracic Society
Oct 16, 2008·Antioxidants & Redox Signaling·Mahmood KhanPeriannan Kuppusamy
Nov 4, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Iyyapu K MohanPeriannan Kuppusamy
Aug 14, 2009·Clinical and Experimental Pharmacology & Physiology·Leonardo dos SantosPaulo J F Tucci
Apr 14, 2010·Emergency Medicine Journal : EMJ·Amanda BurlsJuan B Cabello
Jun 18, 2010·The Cochrane Database of Systematic Reviews·Juan B CabelloTom Quinn
Oct 22, 2010·Circulation·Robert E O'ConnorDemetris Yannopoulos
Feb 3, 2011·Clinical Cardiology·C Richard Conti
Oct 21, 2011·Cardiovascular Research·Mahmood KhanPeriannan Kuppusamy
Oct 25, 2011·The American Journal of Medicine·Richard Kones
Citations
Aug 25, 2019·Cell Biochemistry and Biophysics·Dan Tse, Periannan Kuppusamy
Jan 29, 2021·Oxidative Medicine and Cellular Longevity·Tai-Yu ZhaiYi-Hua Sun
Aug 31, 2020·Redox Biology·Abishai DominicJun-Ichi Abe
Oct 17, 2020·Cardiovascular Research·Xuekun WuKai C Wollert
Jun 17, 2021·Cell Biochemistry and Biophysics·Yazhini RaviPeriannan Kuppusamy